Seminarios Cima 23/24: "A first-in-class HDAC-DNMT1 inhibitor enhances T Cell-mediated cytotoxicity in Pancreatic Ductal Adenocarcinoma"

Seminario Tumores Sólidos | Curso 2023-2024

Shruthi Narayanan, investigadora predoctoral del Programa de Tumores Sólidos realiza el seminario "A first-in-class HDAC-DNMT1 inhibitor enhances T Cell-mediated cytotoxicity in Pancreatic Ductal Adenocarcinoma".

Lugar: Salón de actos Cima